Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason Lauer

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Cardiovascular Diagnosis and Therapy|November 24, 2021
Arterial thoracic outlet syndromeJunjian Huang, Jason Lauer, Omar Zurkiya
Protein and Peptide Letters|March 11, 2010
NMR structure/function relationships of peptides corresponding to the C1B1 Region of PKC gammaJason Lauer, Debarshi Banerjee, Denton Shanks, et al.
Neurosurgical Focus|April 3, 2020
Relative contribution of individual versus combined functional imaging studies in predicting seizure freedom in pediatric epilepsy surgery: an area under the curve analysisPongkiat Kankirawatana, Ismail S Mohamed, Jason Lauer, et al.
Neuro-Oncology Advances|February 6, 2025
Ivosidenib for the treatment of IDH1-mutant glioma, grades 2-4: Tolerability, predictors of response, and outcomesTyler A Lanman, Gilbert Youssef, Raymond Huang, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Cardiovascular Diagnosis and Therapy|November 24, 2021
Arterial thoracic outlet syndromeJunjian Huang, Jason Lauer, Omar Zurkiya
Protein and Peptide Letters|March 11, 2010
NMR structure/function relationships of peptides corresponding to the C1B1 Region of PKC gammaJason Lauer, Debarshi Banerjee, Denton Shanks, et al.
Neurosurgical Focus|April 3, 2020
Relative contribution of individual versus combined functional imaging studies in predicting seizure freedom in pediatric epilepsy surgery: an area under the curve analysisPongkiat Kankirawatana, Ismail S Mohamed, Jason Lauer, et al.
Neuro-Oncology Advances|February 6, 2025
Ivosidenib for the treatment of IDH1-mutant glioma, grades 2-4: Tolerability, predictors of response, and outcomesTyler A Lanman, Gilbert Youssef, Raymond Huang, et al.
Pageof 1